James Cardia

515 total citations
24 papers, 408 citations indexed

About

James Cardia is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, James Cardia has authored 24 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Oncology. Recurrent topics in James Cardia's work include RNA Interference and Gene Delivery (8 papers), Biochemical and Molecular Research (5 papers) and Immunotherapy and Immune Responses (5 papers). James Cardia is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Biochemical and Molecular Research (5 papers) and Immunotherapy and Immune Responses (5 papers). James Cardia collaborates with scholars based in United States, Germany and India. James Cardia's co-authors include Evan R. Kantrowitz, Silvia Corvera, Lawrence M. Lifshitz, Deanna M. Navaroli, Kevin E. Fogarty, Karl Bellvé, Clive Standley, Cheryl L. Wojciechowski, Kimberly A. Stieglitz and Anastasia Khvorova and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

James Cardia

21 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Cardia United States 9 327 64 51 47 31 24 408
Jürgen Kirchberger Germany 11 321 1.0× 81 1.3× 42 0.8× 36 0.8× 19 0.6× 25 438
Duanzhuo Li China 10 286 0.9× 53 0.8× 22 0.4× 66 1.4× 23 0.7× 17 386
Д. К. Новиков Finland 10 371 1.1× 44 0.7× 60 1.2× 64 1.4× 16 0.5× 20 482
Neetu Saxena Canada 8 251 0.8× 97 1.5× 19 0.4× 25 0.5× 13 0.4× 18 368
Paola Cavaliere United States 9 405 1.2× 96 1.5× 15 0.3× 53 1.1× 28 0.9× 14 527
Daniel S. Hitchcock United States 12 308 0.9× 173 2.7× 35 0.7× 36 0.8× 38 1.2× 14 465
Shan He China 12 364 1.1× 49 0.8× 19 0.4× 76 1.6× 43 1.4× 40 540
Thomas J. McCorvie United Kingdom 16 435 1.3× 34 0.5× 72 1.4× 41 0.9× 18 0.6× 23 684
Maria Plana Spain 15 383 1.2× 27 0.4× 25 0.5× 89 1.9× 45 1.5× 43 527
Patricia Ambroziak United States 8 550 1.7× 47 0.7× 17 0.3× 132 2.8× 66 2.1× 8 706

Countries citing papers authored by James Cardia

Since Specialization
Citations

This map shows the geographic impact of James Cardia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Cardia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Cardia more than expected).

Fields of papers citing papers by James Cardia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Cardia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Cardia. The network helps show where James Cardia may publish in the future.

Co-authorship network of co-authors of James Cardia

This figure shows the co-authorship network connecting the top 25 collaborators of James Cardia. A scholar is included among the top collaborators of James Cardia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Cardia. James Cardia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Holton, Katherine, et al.. (2024). Self-Delivering RNAi Compounds for Reduction of Hyperpigmentation. Clinical Cosmetic and Investigational Dermatology. Volume 17. 3033–3044.
3.
Cuiffo, Benjamin, et al.. (2024). Self-delivering RNAi immunotherapeutic PH-762 silences PD-1 to generate local and abscopal antitumor efficacy. Frontiers in Immunology. 15. 1501679–1501679. 1 indexed citations
4.
Weinberg, Andrew D., Brendan D. Curti, Ryan Montler, et al.. (2024). Abstract LB067: Tumor-reactive CD8 TIL with an exhausted phenotype can be expanded and regress human tumors. Cancer Research. 84(7_Supplement). LB067–LB067. 1 indexed citations
5.
6.
7.
Woller, Sarah A., Barbara Morquette, James Cardia, et al.. (2022). Self-delivering RNAi compounds as therapeutic agents in the central nervous system to enhance axonal regeneration after injury. iScience. 25(6). 104379–104379.
8.
Lakshmikanthan, Sribalaji, et al.. (2020). Abstract 2239: Intratumoral delivery of mPH-804 (TIGIT targeting INTASYL compound) inhibits tumor growth and confers an inflammatory tumor microenvironment. Cancer Research. 80(16_Supplement). 2239–2239. 1 indexed citations
9.
Barefoot, L., et al.. (2018). 496 RXI-109 treatment to reduce the formation of hypertrophic dermal scars. Journal of Investigative Dermatology. 138(5). S84–S84. 1 indexed citations
10.
Ly, Socheata, Deanna M. Navaroli, Marie-Cécile Didiot, et al.. (2016). Visualization of self-delivering hydrophobically modified siRNA cellular internalization. Nucleic Acids Research. 45(1). 15–25. 105 indexed citations
11.
Cardia, James, et al.. (2015). Diphencyprone Treatment of Alopecia Areata: Postulated Mechanism of Action and Prospects for Therapeutic Synergy with RNA Interference. Journal of Investigative Dermatology Symposium Proceedings. 17(2). 16–18. 3 indexed citations
12.
Lewis, Geoffrey P., Gabriel Luna, Steven K. Fisher, et al.. (2014). RXI-109 Treatment for Proliferative Vitreoretinopathy (PVR) and other Ocular Disorders. 55(13). 1120–1120. 4 indexed citations
13.
Byrne, Michael, Radouil Tzekov, Yi Wang, et al.. (2013). Novel Hydrophobically Modified Asymmetric RNAi Compounds (sd-rxRNA) Demonstrate Robust Efficacy in the Eye. Journal of Ocular Pharmacology and Therapeutics. 29(10). 855–864. 61 indexed citations
14.
Byrne, Michael, et al.. (2012). Novel Anti-CTGF RNAi Therapy for Treatment of Proliferative Vitreoretinopathy (PVR) and other Ocular Disorders. 53(14). 6262–6262. 1 indexed citations
15.
Salomon, William E., James Cardia, Tod M. Woolf, et al.. (2011). Potent and systematic RNAi mediated silencing with single oligonucleotide compounds. RNA. 17(6). 1032–1037. 7 indexed citations
16.
Cardia, James, et al.. (2007). Use of L‐asparagine and N‐phosphonacetyl‐L‐asparagine to investigate the linkage of catalysis and homotropic cooperativity in E. coli aspartate transcarbomoylase. Proteins Structure Function and Bioinformatics. 71(3). 1088–1096. 3 indexed citations
17.
Heng, Sabrina, et al.. (2006). T-state Inhibitors of E. coli Aspartate Transcarbamoylase that Prevent the Allosteric Transition,. Biochemistry. 45(33). 10062–10071. 10 indexed citations
18.
Stieglitz, Kimberly A., et al.. (2005). Structure of the E.coli Aspartate Transcarbamoylase Trapped in the Middle of the Catalytic Cycle. Journal of Molecular Biology. 352(2). 478–486. 10 indexed citations
19.
Wang, Jie, Kimberly A. Stieglitz, James Cardia, & Evan R. Kantrowitz. (2005). Structural basis for ordered substrate binding and cooperativity in aspartate transcarbamoylase. Proceedings of the National Academy of Sciences. 102(25). 8881–8886. 43 indexed citations
20.
Wojciechowski, Cheryl L., James Cardia, & Evan R. Kantrowitz. (2002). Alkaline phosphatase from the hyperthermophilic bacterium T. maritima requires cobalt for activity. Protein Science. 11(4). 903–911. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jürgen Kirchberger Breakdown of academic impact, for papers by Duanzhuo Li Breakdown of academic impact, for papers by Д. К. Новиков Breakdown of academic impact, for papers by Neetu Saxena Breakdown of academic impact, for papers by Paola Cavaliere Breakdown of academic impact, for papers by Daniel S. Hitchcock Breakdown of academic impact, for papers by Shan He Breakdown of academic impact, for papers by Thomas J. McCorvie Breakdown of academic impact, for papers by Maria Plana Breakdown of academic impact, for papers by Patricia Ambroziak
Rankless by CCL
2026